NCI-H660 Luciferase Reporter Cell Line
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
NCI-H660 Luciferase Reporter Cell Line is generated from NCI-H660 Cell Line, expressing the luciferase gene. The cells constitutively express luciferase.
Species | Human |
Cat.No | ABC-RC678H |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Epithelial |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Prostate |
Disease | Carcinoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Line |
Host Cell | NCI-H660 |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The NCI-H660 Luciferase Reporter Cell Line is generated from the NCI-H660 cell line, which originates from a prostate carcinoma in a 63-year-old male. This reporter line has been genetically modified to constitutively express the luciferase, allowing for bioluminescence-based assays that facilitate the study of gene expression, cellular responses to drugs, and signaling pathways in a cancer research context.
In the NCI-H660 Luciferase Reporter Cell Line, the expression of the luciferase gene is controlled by the EF1α (EFS) promoter. This promoter ensures stable and consistent expression of luciferase, making the cell line suitable for various experimental setups that require reliable reporter activity.
The NCI-H660 Luciferase Reporter Cell Line is primarily used for monitoring gene expression and cellular processes through luciferase assays. It is especially useful in cancer research, drug screening, and the study of gene regulation within the context of neuroendocrine carcinoma of the prostate. Researchers can use this cell line to quantify changes in luciferase activity in response to pharmaceutical treatments or genetic modifications.
The NCI-H660 Luciferase Reporter Cell Line should be cultured in RPMI 1640 medium supplemented with specific components including insulin, transferrin, sodium selenite, hydrocortisone, beta-estradiol, L-glutamine, and 5% fetal bovine serum. The cells exhibit mixed growth properties, with floating aggregates and some attached cells, and should be maintained at 37°C, 5% CO2. Medium renewal is recommended every 2 to 3 days.
The NCI-H660 Luciferase Reporter Cell Line should be stored in the vapor phase of liquid nitrogen. Upon receipt, the cells should be thawed rapidly in a 37°C water bath and transferred to culture under strict aseptic conditions to ensure viability. It is crucial to handle the cells gently and avoid subjecting them to stress or contamination during the thawing and culturing processes.